Cargando…

Is hepatocellular carcinoma surveillance in high-risk populations effective?

Several professional societies recommend hepatocellular carcinoma (HCC) surveillance in high-risk patients including patients with cirrhosis from any etiology and subsets of noncirrhotic chronic hepatitis B virus infection. The efficacy of HCC surveillance to increase early detection and improve sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Onyirioha, Kristeen, Mittal, Sukul, G Singal, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399579/ https://www.ncbi.nlm.nih.gov/pubmed/32774835 http://dx.doi.org/10.2217/hep-2020-0012

Ejemplares similares

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma
por: Parikh, Neehar D., et al.
Publicado: (2016)

Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response
por: Osho, Azeez, et al.
Publicado: (2020)

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
por: Seif El Dahan, Karim, et al.
Publicado: (2023)

Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
por: Hanouneh, Ibrahim A., et al.
Publicado: (2019)

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic
por: Mehta, Neil, et al.
Publicado: (2021)

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
por: Singal, Amit G., et al.
Publicado: (2014)

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort
por: Parikh, Neehar D., et al.
Publicado: (2022)

Perspective: The Mechanobiology of Hepatocellular Carcinoma
por: Loneker, Abigail E., et al.
Publicado: (2021)

Postmarket surveillance of high-risk medical devices needs transparent, comprehensive and independent registries
por: Fraser, Alan G
Publicado: (2020)

Systemic treatment for hepatocellular carcinoma
por: Aggarwal, Manushi, et al.
Publicado: (2018)

A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk
por: Frenette, Catherine T., et al.
Publicado: (2019)

Risk assessment criteria in liver transplantation for hepatocellular carcinoma: proposal to improve transplant oncology
por: McVey, John C, et al.
Publicado: (2020)

Integrated Serologic Surveillance of Population Immunity and Disease Transmission
por: Arnold, Benjamin F., et al.
Publicado: (2018)

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
por: Nguyen, Mindie H., et al.
Publicado: (2022)

Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
por: Yu, Junjie, et al.
Publicado: (2023)

International Circumpolar Surveillance, An Arctic Network for the Surveillance of Infectious Diseases
por: Parkinson, Alan J., et al.
Publicado: (2008)

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
por: Goossens, Nicolas, et al.
Publicado: (2017)

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022)

Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma
por: Simon, Sanford M.
Publicado: (2023)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Daher, Darine, et al.
Publicado: (2023)

The wearable cardioverter-defibrillator is not needed for most high-risk patients
por: Bhatt, Advay G., et al.
Publicado: (2020)

Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma
por: Yoshikawa, Sayuri, et al.
Publicado: (2023)

Comparison of a multitarget blood test to ultrasound and alpha‐fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta‐analysis
por: Singal, Amit G., et al.
Publicado: (2022)

Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression
por: Li, Wei, et al.
Publicado: (2016)

Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development
por: Stice, Camilla P., et al.
Publicado: (2018)

Fragranced Products and VOCs
por: Singal, Madhuri, et al.
Publicado: (2011)

Extending precision medicine tools to populations at high risk of type 2 diabetes
por: Misra, Shivani, et al.
Publicado: (2022)

SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma
por: Shen, Qingyu, et al.
Publicado: (2018)

Sentinel Community-Based Surveillance: An Innovative Mode of Proactive Surveillance on Infectious Disease
por: Liu, Jue, et al.
Publicado: (2023)

Genomic surveillance: a potential shortcut for effective Chagas disease management
por: de Azevedo, Sophia Lincoln Cardoso, et al.
Publicado: (2023)

Obesity: Policy and Practice Recommendations for High-Risk Populations Influenced by the COVID-19 Pandemic
por: Robinson, Kathryn N., et al.
Publicado: (2022)

Potential application of conversational agents in HIV testing uptake among high-risk populations
por: Garett, Renee, et al.
Publicado: (2022)

The Utility of Anatomical Liver Resection in Hepatocellular Carcinoma: Associated with Improved Outcomes or Lack of Supportive Evidence?
por: Ju, Michelle, et al.
Publicado: (2019)

Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma
por: An, Jihyun, et al.
Publicado: (2020)

Real‐world effectiveness of lenvatinib monotherapy in previously treated unresectable hepatocellular carcinoma in US clinical practice
por: Singal, Amit G., et al.
Publicado: (2022)

Deep learning in hepatocellular carcinoma: Current status and future perspectives
por: Ahn, Joseph C, et al.
Publicado: (2021)

Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance
por: Langley, Gayle, et al.
Publicado: (2015)

Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
por: Liu, Qian, et al.
Publicado: (2021)

Positioning of Minimally Invasive Liver Surgery for Hepatocellular Carcinoma: From Laparoscopic to Robot-Assisted Liver Resection
por: Tanaka, Shogo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nfd0gkdjmsp2jo7feqm4tquhv3